ERGIC3, which is regulated by miR-203a, is a potential biomarker for non-small cell lung cancer

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3as a novel lung cancer-related gene

(2013) Mingsong Wu et al.   BMC CANCER

miR-203 Inhibits Cell Proliferation and Migration of Lung Cancer Cells by Targeting PKCα

(2013) Chen Wang et al.   PLoS One

Cancer treatment and survivorship statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3)

(2012) Ling-yun Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines

(2011) Giuditta Viticchiè et al.   CELL CYCLE

microRNA-203 suppresses bladder cancer development by repressing bcl-w expression

(2011) Juanjie Bo et al.   FEBS Journal

The microRNA pathway and cancer

(2010) Pieter Bas Kwak et al.   CANCER SCIENCE

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

(2009) Mayuko Furuta et al.   CARCINOGENESIS

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols